Icds Limited - financial services in Karnataka, India. FY 2026 financials & compliance.
CIN L65993KA1971PLC002106 Incorporated 21 October 1971 ROC Bangalore HQ Karnataka, India
Active Listed - NSE: ICDSLTD · BSE: 511194 Public Limited Company financial services
Data last updated
Market Cap
₹66.10 Cr
ICDSLTD · NSE
Share Price
₹50.74
0.00% today
Revenue
₹2.39 Cr
FY 2025-26 · -38.7% YoY
EBITDA
₹0.26 Cr
Margin 10.9%
Net Profit
₹1.61 Cr
FY 2025-26 · -5.9% YoY
P/E (TTM)
101.4x
P/B 2.2x
ROE
5.5%
ROCE 7.1%
Authorised capital
₹50 Cr
Registered with MCA

About Icds Limited

Data last updated:

Icds Limited is a public limited company based in Karnataka, India. It operates in the non-banking financial services (NBFC) segment of the financial services sector. It was incorporated on 21 October 1971 and has been in existence for over 55 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN L65993KA1971PLC002106. Its GSTIN is 29AAACI4355H1ZI (Karnataka). The company holds 3 GST registrations, of which 2 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 511194 and NSE: ICDSLTD.

The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹13.03 Cr. It is led by directors including Sujir Prabhakar (Managing Director) and Sachin Tonse Pai.

Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Syndicate House Upendra Nagar Manipal, Karnataka, India – 576104.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹2.39 Cr, a decline of 38.7% compared to the previous year. For the same year it recorded a net profit of ₹1.61 Cr (net margin 67.4%) and EBITDA of ₹26 Lakh (EBITDA margin 10.9%). The net worth stands at ₹29.97 Cr (up 3.5% YoY). Total assets are valued at ₹30.53 Cr (up 2.5% YoY).

The company has about 12 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: ICDS Limited. Court records list 2,283 cases involving the company, including 1,878 filed by the company and 406 filed against it; 15 cases are pending. The company has 4 deals on record (4 market trades); the latest was in September 2025.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website icdslimited.com.

Company details

CIN L65993KA1971PLC002106
Registration Number 002106
Incorporation Date 21 October 1971
ROC Bangalore
Listing Status Listed - Listed on NSE (ICDSLTD); Listed on BSE (511194)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

CIN history

Icds has one previous CIN (Corporate Identification Number): U65993KA1971PLC002106. The current CIN is L65993KA1971PLC002106, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L65993KA1971PLC002106Current
U65993KA1971PLC002106Previous

Contact details

Icds Limited's registered office is in Karnataka. Its website is icdslimited.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Syndicate House Upendra Nagar Manipal, Karnataka, India – 576104
  • Industry
    Financial Services, NBFC

To see the full contact details of Icds Limited, buy the company report.

Comprehensive company report
Icds Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Icds operates one associated brand: ICDS Limited. Each brand links to its own profile.

BrandDescriptionWebsite
Financial services are provided by ICDS in India since 1971.icdslimited.com

Business activity

The main business activities of Icds are financial and insurance service, trade and real estate. In detail, this covers financial and credit leasing activities, retail trading and real estate activities with own or leased property. 3 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
KFinancial and insurance ServiceK5Financial and Credit leasing activities
GTradeG2Retail Trading
LReal EstateL1Real estate activities with own or leased property

To see the full business activity and turnover split of Icds Limited, buy the company report.

Financials of Icds Limited

FY 2025-26 filings available

Icds Limited reported revenue of ₹2.39 Cr (down 38.7% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹2.39 Cr
-38.7% YoY
EBITDA
₹0.26 Cr
-87.4% YoY
Profit After Tax
₹1.61 Cr
-5.8% YoY
Net Worth
₹29.97 Cr
+3.5% YoY
Total Assets
₹30.53 Cr
+2.5% YoY
Total Debt
Nil

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2.393.902.281.921.421.053.11
Revenue growth-38.7%+71.1%+18.8%+35.2%+35.2%-66.2%-
EBITDA0.262.060.850.12(0.24)(0.66)(0.67)
EBITDA margin+10.9%+52.8%+37.3%+6.3%-16.9%-62.9%-21.5%
Profit before tax1.362.932.370.535.951.03(0.73)
Net profit1.611.712.050.37(0.57)(5.37)(1.13)
Net profit margin+67.4%+43.9%+89.9%+19.3%-40.1%-511.4%-36.3%
EPS (₹)0.841.081.560.294.48(4.13)(0.62)
Balance sheet
Total assets30.5329.7828.1926.5526.2620.2225.47
Net worth29.9728.9527.5425.5225.2219.3724.84
Total debt0.000.260.130.300.480.140.20
Cash & bank4.171.913.555.202.102.543.13
Net working capital8.475.979.715.368.552.522.81
Cash flow
Cash from operations1.621.060.206.36(0.54)(0.88)(1.92)
Cash from investing(0.83)(1.42)0.23(6.17)0.230.912.46
Cash from financing(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.610.520.570.530.772.350.510.53
Revenue growth (YoY)-20.8%-77.9%+11.8%0.0%+48.1%---
Other income1.120.060.38(0.17)1.27(0.48)0.390.70
EBITDA0.00(0.44)0.250.100.361.510.160.26
EBITDA margin0.0%-84.6%+43.9%+18.9%+46.8%+64.3%+31.4%+49.1%
Depreciation0.090.100.100.090.090.090.090.09
Interest0.020.010.020.010.020.020.020.02
Profit before tax1.01(0.49)0.51(0.17)1.520.920.440.85
Tax0.08(0.08)0.070.130.150.081.220.20
Net profit0.93(0.41)0.44(0.30)1.370.84(0.78)0.65
EPS (₹)0.72(0.32)0.35(0.24)1.060.64(0.59)0.50
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1.653.181.571.331.032.833.21
Revenue growth-48.1%+102.6%+18.1%+29.1%-63.6%-11.8%-
EBITDA(0.38)1.420.24(0.27)(0.54)1.21(0.41)
EBITDA margin-23.0%+44.7%+15.3%-20.3%-52.4%+42.8%-12.8%
Profit before tax0.562.181.750.165.680.89(0.43)
Net profit0.981.131.560.06(0.84)(5.47)(0.80)
Net profit margin+59.4%+35.5%+99.4%+4.5%-81.6%-193.3%-24.9%
EPS (₹)0.360.621.190.054.32(4.20)(0.38)
Balance sheet
Total assets25.6725.5324.6023.2223.4317.6023.16
Net worth25.3424.9524.1422.5922.6116.9722.53
Total debt0.000.260.130.300.480.140.20
Cash & bank3.141.463.494.481.902.531.15
Net working capital6.424.518.754.688.362.581.20
Cash flow
Cash from operations1.190.64(0.28)5.85(0.73)(0.86)(1.58)
Cash from investing(0.59)(1.00)0.71(5.65)0.400.962.05
Cash from financing(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.420.330.390.350.592.160.330.35
Revenue growth (YoY)-28.8%-84.7%+18.2%0.0%+73.5%---
Other income1.060.000.33(0.22)1.23(0.53)0.340.66
Total expenses0.550.940.300.410.380.820.330.25
EBITDA(0.13)(0.61)0.09(0.06)0.211.340.000.10
EBITDA margin-31.0%-184.8%+23.1%-17.1%+35.6%+62.0%0.0%+28.6%
Depreciation0.090.090.090.090.090.090.090.09
Interest0.010.010.010.010.010.010.010.01
Profit before tax0.83(0.71)0.32(0.38)1.340.710.240.66
Tax0.04(0.12)0.030.090.110.031.180.16

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 27 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.610.520.570.530.772.350.510.53
Revenue growth (YoY)-20.8%-77.9%+11.8%0.0%+48.1%---
Other income1.120.060.38(0.17)1.27(0.48)0.390.70
EBITDA0.00(0.44)0.250.100.361.510.160.26
EBITDA margin0.0%-84.6%+43.9%+18.9%+46.8%+64.3%+31.4%+49.1%
Depreciation0.090.100.100.090.090.090.090.09
Interest0.020.010.020.010.020.020.020.02
Profit before tax1.01(0.49)0.51(0.17)1.520.920.440.85
Tax0.08(0.08)0.070.130.150.081.220.20
Net profit0.93(0.41)0.44(0.30)1.370.84(0.78)0.65
EPS (₹)0.72(0.32)0.35(0.24)1.060.64(0.59)0.50
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2.393.902.281.921.421.053.11
Revenue growth-38.7%+71.1%+18.8%+35.2%+35.2%-66.2%-
Other income1.541.321.960.836.592.110.37
Total expenses2.131.841.431.801.661.713.78
Employee cost0.480.550.660.730.610.740.86
EBITDA0.262.060.850.12(0.24)(0.66)(0.67)
EBITDA margin+10.9%+52.8%+37.3%+6.3%-16.9%-62.9%-21.5%
Depreciation0.380.370.360.360.330.340.35
Interest0.060.080.080.060.070.080.08
Profit before tax1.362.932.370.535.951.03(0.73)
Tax0.281.530.320.160.106.400.11
Net profit1.611.712.050.37(0.57)(5.37)(1.13)
Net profit margin+67.4%+43.9%+89.9%+19.3%-40.1%-511.4%-36.3%
EPS (₹)0.841.081.560.294.48(4.13)(0.62)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital13.0313.0313.0313.0313.0313.0313.03
Reserves & surplus16.9415.9214.5112.4912.196.3411.81
Shareholders' funds (net worth)29.9728.9527.5425.5225.2219.3724.84
Minority interest0.000.000.000.000.000.000.00
Secured loans0.000.260.130.300.480.140.20
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.260.130.300.480.140.20
Total liabilities30.5329.7828.1926.5526.2620.2225.47
Assets
Gross block12.2612.2212.1112.1512.1411.8511.85
Net block9.409.739.9910.3810.7310.7811.12
Capital work in progress0.000.000.000.000.000.000.00
Investments5.155.815.824.344.154.542.50
Inventories0.000.000.000.000.000.000.00
Sundry debtors0.090.090.180.080.070.110.11
Cash & bank balances4.171.913.555.202.102.543.13
Loans & advances6.616.396.460.366.730.130.10
Total current assets10.878.3910.195.648.902.783.34
Total current liabilities2.402.420.480.280.350.260.53
Net working capital8.475.979.715.368.552.522.81
Total assets30.5329.7828.1926.5526.2620.2225.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.080.330.070.080.070.120.12
Net cash from operating activities1.621.060.206.36(0.54)(0.88)(1.92)
Net cash from investing activities(0.83)(1.42)0.23(6.17)0.230.912.46
Net cash from financing activities(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
Net change in cash0.52(0.25)0.25(0.01)0.01(0.04)(0.01)
Closing cash4.171.913.555.202.102.543.13
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-38.7%+71.1%+18.8%+35.2%+35.2%-66.2%-
EBITDA growth-87.4%+142.4%+608.3%+150.0%+63.6%+1.5%-
PBT growth-53.6%+23.6%+347.2%-91.1%+477.7%+9998.0%+58.1%
Net income growth-5.9%-16.6%+454.1%+164.9%+89.4%-375.2%-
Revenue CAGR (3Y)+7.6%+40.0%+29.5%-14.9%-24.4%-45.4%+3.6%
EBITDA CAGR (3Y)+29.4%----50.7%--
Profitability & leverage
Net income margin+45.2%+35.9%+89.9%+19.3%+412.0%-511.4%-27.0%
Return on capital employed+7.1%+11.6%+9.0%+2.2%-2.2%0.0%-3.6%
Return on net worth+5.5%+6.1%+7.7%+1.5%-2.6%0.0%-4.4%
Debt / equity0.000.010.010.020.010.010.02
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-50.004.7316.33-25.00-12.28-8.00-7.84
Efficiency & per share
Fixed asset turnover0.200.320.190.160.670.090.35
Inventory turnover0.000.000.000.000.000.000.00
Debtors turnover26.5628.8917.5425.6089.009.5536.63
EPS (₹)0.841.081.560.294.48(4.13)(0.62)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)23.0022.2221.1419.5919.3614.8619.06
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.420.330.390.350.592.160.330.35
Revenue growth (YoY)-28.8%-84.7%+18.2%0.0%+73.5%---
Other income1.060.000.33(0.22)1.23(0.53)0.340.66
Total expenses0.550.940.300.410.380.820.330.25
EBITDA(0.13)(0.61)0.09(0.06)0.211.340.000.10
EBITDA margin-31.0%-184.8%+23.1%-17.1%+35.6%+62.0%0.0%+28.6%
Depreciation0.090.090.090.090.090.090.090.09
Interest0.010.010.010.010.010.010.010.01
Profit before tax0.83(0.71)0.32(0.38)1.340.710.240.66
Tax0.04(0.12)0.030.090.110.031.180.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1.653.181.571.331.032.833.21
Revenue growth-48.1%+102.6%+18.1%+29.1%-63.6%-11.8%-
Other income1.331.151.900.816.590.060.37
Total expenses2.031.761.331.601.571.623.62
Employee cost0.480.550.660.730.610.740.85
EBITDA(0.38)1.420.24(0.27)(0.54)1.21(0.41)
EBITDA margin-23.0%+44.7%+15.3%-20.3%-52.4%+42.8%-12.8%
Depreciation0.360.350.350.350.320.320.33
Interest0.030.040.040.030.050.060.06
Profit before tax0.562.181.750.165.680.89(0.43)
Tax0.111.370.190.100.066.360.07
Net profit0.981.131.560.06(0.84)(5.47)(0.80)
Net profit margin+59.4%+35.5%+99.4%+4.5%-81.6%-193.3%-24.9%
EPS (₹)0.360.621.190.054.32(4.20)(0.38)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital13.0313.0313.0313.0313.0313.0313.03
Reserves & surplus12.3111.9211.119.569.583.949.50
Shareholders' funds (net worth)25.3424.9524.1422.5922.6116.9722.53
Secured loans0.000.260.130.300.480.140.20
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.260.130.300.480.140.20
Total liabilities25.6725.5324.6023.2223.4317.6023.16
Assets
Gross block9.409.369.269.299.298.998.99
Net block6.707.017.267.637.987.998.32
Capital work in progress0.000.000.000.000.000.000.00
Investments5.275.925.944.454.264.652.61
Inventories0.000.000.000.000.000.000.00
Sundry debtors0.090.090.180.080.070.080.11
Cash & bank balances3.141.463.494.481.902.531.15
Loans & advances5.375.165.260.356.720.190.22
Total current assets8.606.718.934.918.692.801.48
Total current liabilities2.182.200.180.230.330.220.28
Net working capital6.424.518.754.688.362.581.20
Total assets25.6725.5324.6023.2223.4317.6023.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.050.300.050.050.060.040.11
Net cash from operating activities1.190.64(0.28)5.85(0.73)(0.86)(1.58)
Net cash from investing activities(0.59)(1.00)0.71(5.65)0.400.962.05
Net cash from financing activities(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
Net change in cash0.33(0.25)0.250.00(0.02)0.02(0.07)
Closing cash3.141.463.494.481.902.531.15
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-48.1%+102.6%+18.1%+29.1%-63.6%-11.8%-
EBITDA growth-126.8%+491.7%+188.9%+50.0%-144.6%+395.1%-
PBT growth-74.3%+24.6%+993.8%-97.2%+538.2%+9998.0%+76.5%
Net income growth-13.3%-27.6%+2500.0%+107.1%+84.6%-583.8%-
Revenue CAGR (3Y)+7.5%+45.6%-17.8%-25.5%-30.4%-25.0%+6.5%
EBITDA CAGR (3Y)+12.1%--41.7%-13.0%-36.7%-37.3%-
Profitability & leverage
Net income margin+27.3%+25.5%+99.4%+4.5%+545.6%-193.3%-15.6%
Return on capital employed+5.1%+10.3%+7.5%+0.8%-3.9%0.0%-2.9%
Return on net worth+3.9%+4.6%+6.7%+0.3%-4.2%0.0%-3.5%
Debt / equity0.010.010.010.020.020.010.02
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-4.053.74-36.36-4.84-5.816.74-8.11
Efficiency & per share
Fixed asset turnover0.180.340.170.140.830.320.51
Inventory turnover0.000.000.000.000.000.000.00
Debtors turnover18.3323.5612.0817.73101.6030.4237.68
EPS (₹)0.360.621.190.054.32(4.20)(0.38)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)19.4519.1518.5317.3417.3513.0317.29

To see the full year-wise statements and ratios of Icds Limited, buy the company report.

Board of directors of Icds Limited

Icds has 6 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sujir PrabhakarManaging Director05 Dec 20187 Years 10 MonthsCurrent
Sachin Tonse PaiDirector05 Dec 20187 Years 10 MonthsCurrent
Kalsank Umesh KiniDirector24 Feb 20233 Years 8 MonthsCurrent
Jayaram Vittal PrabhuDirector26 Sep 20242 Years 1 MonthsCurrent
Roopashree RoopashreeDirector04 Dec 20232 Years 10 MonthsCurrent
Katapady Bhujangesha KamathDirector04 Dec 20232 Years 10 MonthsCurrent

Auditor

Icds Limited is audited by CHATURVEDI & SHAH LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
CHATURVEDI & SHAH LLPFY 2023101720W/W100355

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 51.40%, foreign institutional investors hold 0.00%, domestic institutional investors hold 4.90% and retail and other public shareholders hold 43.70%.

Promoters: 51.40%DII (Domestic Institutional): 4.90%Retail & Others: 43.70%
Sep 2026
QUARTER
51.40% Promoters
4.90% DII (Domestic Institutional)
43.70% Retail & Others
Promoter holding - history
Now 51.40% · Sep 2026High 51.40% · Dec 2025Low 51.40% · Dec 2025
50%50.8%51.5%52.3%53%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 51.40%Mar 2026: 51.40%Jun 2026: 51.40%Sep 2026: 51.40%51.40%51.40%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters51.40%51.40%51.40%51.40%
Public48.60%48.60%48.60%48.60%

Deals & funding

Icds Limited has 4 deals on record (4 market trades); the latest was in September 2025.

Total deals
4
Market trades
4

Deals on record (4 of 4)

WhenDealAmountParties
Sep 2025Market trade₹70.5 LakhBuyer: Irage Broking Services LLP , Orion Stocks Limited
Seller: Orion Stocks Limited , Irage Broking Services LLP
Sep 2025Market trade₹62.2 LakhBuyer: Orion Stocks Limited , Irage Broking Services LLP
Seller: Irage Broking Services LLP , Orion Stocks Limited
Mar 2025Market trade₹75.6 LakhBuyer: Kanara Consumer Products Limited
Seller: Manipal High School Trust
Oct 2021Market trade₹56.4 LakhBuyer: Alpha Leon Enterprises LLP
Seller: Alpha Leon Enterprises LLP

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Icds Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Icds has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Manipal Properties LimitedU45201TN1999PLC043271

To see the full group structure of Icds Limited, buy the company report.

Employees & EPFO

Icds Limited has a workforce of 12 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.

Employee count
12
Active EPFO establishments
1
Employee growth
-14.29%

GST

Icds has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
29AAACI4355H1ZIKarnatakaActive01 Jul 2017
33AAACI4355H1ZTTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Icds Limited, buy the company report.

Recent activity

Icds Limited has 28 board changes on record since 1973: 17 appointments and 11 cessations. The latest: Shrikanth Prabhu ceased to be Director on 01 Aug 2025.

Filing
Icds Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Bangalore.
AGM
Icds Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Ceased
Shrikanth Prabhu ceased to be Director.
Appointed
Shrikanth Prabhu was appointed as Director.
Ceased
Airody Giridhar Pai ceased to be Director.
Appointed
Jayaram Vittal Prabhu was appointed as Director.
Ceased
Bharath Krishna Nayak ceased to be Managing Director.
Appointed
Katapady Bhujangesha Kamath was appointed as Director.
Appointed
Roopashree Roopashree was appointed as Director.
Ceased
Vimal Kamath Chandrashekhar ceased to be Director.
Ceased
Govindaraya Nayak Raman ceased to be CFO.
Appointed
Kalsank Umesh Kini was appointed as Director.

19 earlier events are in the company report.

Frequently asked questions

Icds is an active public limited company based in Karnataka, India. The company works in nbfc, within the financial services industry. It was incorporated on 21 October 1971 (55+ years old) and is registered under CIN L65993KA1971PLC002106. Listed on BSE: 511194 and NSE: ICDSLTD.

Icds reported revenue of ₹2.39 Cr for FY 2025-26 (down 38.7% YoY) based on consolidated financials.

Icds has 6 current directors:

The latest financial statements of Icds on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Icds is 29AAACI4355H1ZI, registered in Karnataka. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 33AAACI4355H1ZT (Tamil Nadu).

The CIN (Corporate Identification Number) of Icds is L65993KA1971PLC002106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Icds is a listed company as per MCA records. Its shares are listed on both BSE (code: 511194) and NSE (symbol: ICDSLTD).

Icds has 2,283 court cases on record: 1,878 filed by the company and 406 filed against it. 15 are pending. Most are in the district courts.

Icds was incorporated on 21 October 1971, making it 55+ years old. It is registered with the Registrar of Companies, Bangalore.

Icds has 4 deals on record (4 market trades); the latest was in September 2025.